Contemporary Oncology
eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2025
vol. 29
 
Share:
Send email
Share:
abstract:
Original paper

Enhanced antitumour efficacy of ferulic acid nanoparticles in combination with doxorubicin – a promising strategy for breast cancer treatment

Alshimaa F. Salama
1
,
Gamal A. Omran
1
,
Ahmad M. Salahuddin
1
,
Heba M. Abd-El-Azim
2
,
Ahmed Noreldin
3
,
Tarek M. Okda
1

  1. Biochemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt
  2. Pharmaceutics Department, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt
  3. Histology and Cytology Department, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
Contemp Oncol (Pozn) 2025; 29 (3): 297–315
DOI: https://doi.org/10.5114/wo.2025.151917
Online publish date: 2025/06/09
View full text Get citation
 
PlumX metrics:
Introduction:
The discovery of anticancer drugs from natural plants represents a large interest around the world. Ferulic acid (FA) is a natural phenolic acid has antitumor activity. Doxorubicin (DOX) is a potent chemotherapeutic agent used in the treatment of breast cancer, but its clinical uses are limited due to its toxic effects. This study aimed to evaluate the antitumour effect of FA and its nanosuspension (FA-NS) alone and in combination with DOX in Ehrlich solid tumour (EST)-bearing mice.

Material and methods:
Thirty-five female mice were divided into 7 groups: control, EST, FA, FA-NS, DOX, FA + DOX, and FA-NS + DOX. Proliferation, autophagy, apoptosis, angiogenesis, oxidative stress, and total antioxidant capacity (TAC) were investigated.

Results:
Our results showed that FA alone or in combination with DOX decreased tumour weight, proliferation, and angiogenesis by downregulating AKT and vascular endothelial growth factor receptor 2 levels, with marked elevation in autophagy and apoptosis indicated by upregulating Beclin-1, LC3-II, and caspase-3 levels. In addition, reduction of oxidative stress was indicated by decreased malondialdehyde and elevated TAC levels. Interestingly, the combination treatment mitigates DOX-induced different toxicities through the reduction of high levels of troponin-1, creatine kinase-MB, alanine transaminase, aspartate transaminase, urea, and creatinine.

Conclusions:
The combination of FA with DOX has the ability not only to promote the antitumour activity of DOX but also to ameliorate the side effects of DOX with more significant results when the FA was formulated by the nanotechnology.

keywords:

breast cancer, ferulic acid, doxorubicin, autophagy, angiogenesis, apoptosis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.